End-of-life experience of children undergoing stem cell transplantation for malignancy: parent and provider perspectives and patterns of care
Authors:
- 13 May 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 115 (19) , 3879-3885
Abstract
The end-of-life (EOL) experience of children who undergo stem cell transplantation (SCT) may differ from that of other children with cancer. To evaluate perspectives and patterns of EOL care after SCT, we surveyed 141 parents of children who died of cancer (response rate, 64%) and their physicians. Chart review provided additional information. Children for whom SCT was the last cancer therapy (n = 31) were compared with those for whom it was not (n = 110). SCT parents and physicians recognized no realistic chance for cure later than non-SCT peers (both P < .001) and were more likely to have a primary goal of cure at death (parents, P < .001; physicians, P = .02). SCT children were more likely to suffer highly from their last cancer therapy and die in the intensive care unit (both P < .001), with less opportunity for EOL preparation. SCT parents who recognized no realistic chance for cure more than 7 days before death along with the physician were more likely to prepare for EOL, and if their primary goal was to reduce suffering, to achieve this (P < .001). SCT is associated with significant suffering and less opportunity to prepare for EOL. Children and families undergoing SCT may benefit from ongoing discussions regarding prognosis, goals, and opportunities to maximize quality of life.Keywords
This publication has 50 references indexed in Scilit:
- Parents’ Views of Cancer-Directed Therapy for Children With No Realistic Chance for CureJournal of Clinical Oncology, 2008
- Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL™ 4.0 Generic Core ScalesHealth and Quality of Life Outcomes, 2007
- Palifermin Reduces Patient-Reported Mouth and Throat Soreness and Improves Patient Functioning in the Hematopoietic Stem-Cell Transplantation SettingJournal of Clinical Oncology, 2006
- Symptoms Affecting Children With Malignancies During the Last Month of Life: A Nationwide Follow-upPediatrics, 2006
- Palifermin for Oral Mucositis after Intensive Therapy for Hematologic CancersNew England Journal of Medicine, 2004
- Talking about Death with Children Who Have Severe Malignant DiseaseNew England Journal of Medicine, 2004
- The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the Medical Research Council UKALLR1 studyBritish Journal of Haematology, 2000
- Patient-controlled analgesia for mucositis pain in children: A three-period crossover study comparing morphine and hydromorphoneThe Journal of Pediatrics, 1996
- Efficacy and safety of ondansetron in pediatric patients undergoing bone marrow transplantationClinical Therapeutics, 1996
- Use of patient-controlled analgesia for pain control for children receiving bone marrow transplantJournal of Pain and Symptom Management, 1995